ctDNA and late recurrence in high-risk, HR+, HER2- breast cancer VJOncology 1:46 2 years ago 2 044 Скачать Далее
N9831 trial: genes associated with early and late recurrence in HER2+ breast cancer VJOncology 2:13 1 year ago 242 Скачать Далее
Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients ecancer 10:17 6 years ago 4 188 Скачать Далее
MiRaDor: monitoring MRD using ctDNA in HR+/HER2- early breast cancer VJOncology 1:31 6 months ago 83 Скачать Далее
Real-world monitoring of circulating tumor DNA to predict cancer recurrence VJOncology 0:58 1 year ago 206 Скачать Далее
Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer PeerView Oncology 58:22 2 years ago 3 472 Скачать Далее
ctDNA in Breast Cancer | 2023 COEDS Discussion Series Fort Lauderdale Total Health | Oncology 16:11 1 year ago 186 Скачать Далее
ctDNA assay for detection of recurrent disease in patients with early-stage breast cancer VJOncology 1:36 2 years ago 109 Скачать Далее
BioltaLEE: ctDNA dynamics in HR+/HER2- advanced breast cancer VJOncology 4:10 2 years ago 114 Скачать Далее
Defining Optimal Therapy in High-Risk Early Breast Cancer #shorts Medscape 1:00 2 years ago 745 Скачать Далее
ASCO22: Marla Lipsyc-Sharf, MD on ctDNA in breast cancer | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 1:43 2 years ago 283 Скачать Далее
Assessing elacestrant in ctDNA-positive patients with ER+ breast cancer VJOncology 3:01 2 years ago 208 Скачать Далее
Dr. Holmes Discusses Late Recurrence and the MA.17 Trial in Breast Cancer OncLive 2:27 7 years ago 236 Скачать Далее
New horizons in high-risk HR+ HER2- EBC: Risk stratification for early identification Touch Medical Media Services 40:56 2 years ago 651 Скачать Далее
SUCCESS-A trial: ctDNA screening's potential in early-stage breast cancer recurrence prediction VJOncology 1:46 7 months ago 266 Скачать Далее
